{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:12:34Z","timestamp":1786986754396,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.chroma.2017.03.059","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T23:47:31Z","timestamp":1490312851000},"page":"110-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["High performance liquid chromatography with photo diode array for separation and analysis of naproxen and esomeprazole in presence of their chiral impurities: Enantiomeric purity determination in tablets"],"prefix":"10.1016","volume":"1497","author":[{"given":"Marwa A.A.","family":"Ragab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman I.","family":"El-Kimary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2017.03.059_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-022X(02)00124-0","article-title":"The importance of stereoselective determination of drugs in the clinical laboratory","volume":"54","author":"Rentsch","year":"2002","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.chroma.2017.03.059_bib0010","series-title":"Chiral Drugs: Chemistry and Biological Action","author":"Lin","year":"2011"},{"key":"10.1016\/j.chroma.2017.03.059_bib0015","series-title":"Chirality in Industry II: Developments in the Commercial Manufacture and Applications of Optically Active Compounds","author":"Collins","year":"1997"},{"key":"10.1016\/j.chroma.2017.03.059_bib0020","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/chir.530040513","article-title":"FDA\u2019s policy statement for the development of new stereoisomeric drugs","volume":"4","year":"1992","journal-title":"Chirality"},{"key":"10.1016\/j.chroma.2017.03.059_bib0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.59566\/IJBS.2006.2085","article-title":"Chiral drugs: an overview","volume":"2","author":"Nguyen","year":"2006","journal-title":"Int. J. Biomed. Sci."},{"key":"10.1016\/j.chroma.2017.03.059_bib0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0165-022X(02)00127-6","article-title":"Resolution of chiral drugs by liquid chromatography based upon diastereomer formation with chiral derivatization reagents","volume":"54","author":"Toyo\u2019oka","year":"2002","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.chroma.2017.03.059_bib0035","series-title":"Chiral Separations by Liquid Chromatography and Related Technologies","first-page":"1","article-title":"Introduction","author":"Aboun-Enein","year":"2003"},{"key":"10.1016\/j.chroma.2017.03.059_bib0040","series-title":"Chiral Separations: Methods and Protocols","first-page":"1","article-title":"Chiral separation principles","author":"Gubitz","year":"2004"},{"key":"10.1016\/j.chroma.2017.03.059_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9673(97)00585-2","article-title":"Chiral packed column subcritical fluid chromatography on polysaccharide and macrocyclic antibiotic chiral stationary phases","volume":"785","author":"Medvedovici","year":"1997","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2017.03.059_bib0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1872-2040(07)60028-0","article-title":"Enantiomeric separation of naproxen by high performance liquid chromatography using CHIRALCEL OD as stationary phase","volume":"35","author":"De-Miao","year":"2007","journal-title":"Chin. J. Anal. Chem."},{"key":"10.1016\/j.chroma.2017.03.059_bib0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/00003088-200140060-00003","article-title":"Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole","volume":"40","author":"Andersson","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.chroma.2017.03.059_bib0060","first-page":"728","article-title":"Guidelines for prevention of NSAIDrelated ulcer complications","volume":"104","author":"Lanza","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.chroma.2017.03.059_bib0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0021-9673(01)00555-6","article-title":"Uniformly sized molecularly imprinted polymer for (S)-naproxen: Retention and molecular recognition properties in aqueous mobile phase","volume":"913","author":"Haginaka","year":"2001","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2017.03.059_bib0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02290496","article-title":"Stereochemical resolution of enantiomeric 2-aryl propionic acid non-steroidal anti-inflammatory drugs on a human serum albumin based high-performance liquid chromatographic chiral stationary phase","volume":"31","author":"Noctor","year":"1991","journal-title":"Chromatographia"},{"key":"10.1016\/j.chroma.2017.03.059_bib0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5740\/jaoacint.12-200","article-title":"Chiral separation of racemic naproxen by high-performance liquid chromatography with beta-CD\/SiO2 as the chiral stationary phase","volume":"97","author":"Wang","year":"2014","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.chroma.2017.03.059_bib0080","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/jssc.200401835","article-title":"Chiral separation of omeprazole and several related benzimidazoles using supercritical fluid chromatography","volume":"27","author":"Del Nozal","year":"2004","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.chroma.2017.03.059_bib0085","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/0975-7406.80766","article-title":"Development and validation of a stability indicating method for the enantioselective estimation of omeprazole enantiomers in the enteric-coated formulations by high-performance liquid chromatography","volume":"3","author":"Vyas","year":"2011","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.chroma.2017.03.059_bib0090","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1590\/S0103-50532004000200025","article-title":"Enantioselective analysis of omeprazole in pharmaceutical formulations by chiral high-performance liquid chromatography and capillary electrophoresis","volume":"15","author":"BonatoI","year":"2004","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.chroma.2017.03.059_bib0095","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/bmc.2878","article-title":"Development and validation of a sensitive and high-throughput LC-MS\/MS method for the simultaneous determination of esomeprazole and naproxen in human plasma","volume":"27","author":"Gopinatha","year":"2013","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.chroma.2017.03.059_bib0100","first-page":"553","article-title":"Stability indicating simultaneous estimation of assay method for naproxen and esomeprazole in pharmaceutical formulations by RP-HPLC","volume":"3","author":"Reddy","year":"2011","journal-title":"Der Pharma Chem."},{"key":"10.1016\/j.chroma.2017.03.059_bib0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1556\/JPC.28.2015.1.12","article-title":"A validated high-performance thin-layer chromatographic method for the assay of two binary mixtures containing omeprazole or its isomer esomeprazole in pharmaceutical dosage forms","volume":"28","author":"El-Kimary","year":"2015","journal-title":"J. Planar Chromatogr."},{"key":"10.1016\/j.chroma.2017.03.059_bib0110","series-title":"International Conference on Harmonisation","article-title":"Validation of analytical procedures text and methodology Q2 (R1)","author":"ICH","year":"2005"}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967317304545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967317304545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T05:44:44Z","timestamp":1758260684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967317304545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":22,"alternative-id":["S0021967317304545"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2017.03.059","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High performance liquid chromatography with photo diode array for separation and analysis of naproxen and esomeprazole in presence of their chiral impurities: Enantiomeric purity determination in tablets","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2017.03.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}